AG˹ٷ

STOCK TITAN

[Form 4] Becton, Dickinson and Co. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Resideo Technologies, Inc. (REZI) filed a Form 144 disclosing a planned disposition of 5,579 common shares via Morgan Stanley Smith Barney on 07 July 2025. The stock originates from restricted stock units granted on 16 November 2022 and carries an estimated market value of $134,342. With 148,503,534 shares currently outstanding, the sale equals roughly 0.004 % of total shares—an amount generally viewed as immaterial to the company’s float. The filer reported no other sales in the past three months, and the notice contains no commentary on company operations or outlook.

Resideo Technologies, Inc. (REZI) ha presentato un Modulo 144 comunicando una prevista cessione di 5.579 azioni ordinarie tramite Morgan Stanley Smith Barney il 07 luglio 2025. Le azioni derivano da unità azionarie vincolate concesse il 16 novembre 2022 e hanno un valore di mercato stimato di 134.342 $. Con 148.503.534 azioni attualmente in circolazione, la vendita rappresenta circa lo 0,004 % del totale delle azioni, una quantità generalmente considerata irrilevante per il flottante della società. Il dichiarante ha segnalato nessuna altra vendita negli ultimi tre mesi e l’avviso non contiene commenti sulle operazioni o sulle prospettive dell’azienda.

Resideo Technologies, Inc. (REZI) presentó un Formulario 144 revelando una disposición planificada de 5.579 acciones comunes a través de Morgan Stanley Smith Barney el 07 de julio de 2025. Las acciones provienen de unidades de acciones restringidas otorgadas el 16 de noviembre de 2022 y tienen un valor de mercado estimado de $134,342. Con 148,503,534 acciones actualmente en circulación, la venta equivale aproximadamente al 0.004 % del total de acciones, una cantidad generalmente considerada insignificante para el flotante de la empresa. El declarante reportó ninguna otra venta en los últimos tres meses y el aviso no contiene comentarios sobre las operaciones o perspectivas de la compañía.

Resideo Technologies, Inc. (REZI)� 2025� 7� 7� Morgan Stanley Smith Barney� 통해 5,579�� 보통� 처분 계획� 공개하는 Form 144� 제출했습니다. 해당 주식은 2022� 11� 16일에 부여된 제한 주식 단위에서 기인하며, 추정 시장 가치는 134,342달러입니�. 현재 148,503,534주가 유통 중인 가운데, 이번 매각은 전체 주식� � 0.004%� 해당하며, 이는 일반적으� 회사 유통 주식 수에 크게 영향� 미치지 않는 수준입니�. 제출자는 지� 3개월 동안 다른 매각� 없었�� 보고했으�, 공지에는 회사 운영이나 전망� 대� 언급� 없습니다.

Resideo Technologies, Inc. (REZI) a déposé un formulaire 144 révélant une cession prévue de 5 579 actions ordinaires via Morgan Stanley Smith Barney le 07 juillet 2025. Les actions proviennent de unités d’actions restreintes attribuées le 16 novembre 2022 et ont une valeur marchande estimée à 134 342 $. Avec 148 503 534 actions actuellement en circulation, la vente représente environ 0,004 % du total des actions, un montant généralement considéré comme négligeable pour le flottant de la société. Le déclarant a indiqué aucune autre vente au cours des trois derniers mois, et l’avis ne contient aucun commentaire sur les opérations ou les perspectives de l’entreprise.

Resideo Technologies, Inc. (REZI) hat ein Formular 144 eingereicht, in dem eine geplante Veräußerung von 5.579 Stammaktien über Morgan Stanley Smith Barney am 07. Juli 2025 offengelegt wird. Die Aktien stammen von Restricted Stock Units, die am 16. November 2022 gewährt wurden, und haben einen geschätzten Marktwert von 134.342 $. Bei derzeit 148.503.534 ausstehenden Aktien entspricht der Verkauf etwa 0,004 % der Gesamtaktien � ein Betrag, der allgemein als unerheblich für den Streubesitz des Unternehmens angesehen wird. Der Meldende gab an, in den letzten drei Monaten keine weiteren Verkäufe getätigt zu haben, und die Mitteilung enthält keine Kommentare zu den Geschäftstätigkeiten oder der Perspektive des Unternehmens.

Positive
  • None.
Negative
  • None.

Insights

TL;DR Routine Form 144 for 5,579 REZI shares (~$134k); negligible 0.004% float impact, signalling standard insider liquidity.

The filing outlines a modest prospective insider sale valued at $134k. Given the company’s 148.5 million shares outstanding, the transaction is far below any threshold that would influence liquidity, ownership structure, or market sentiment. No accompanying material disclosures or pattern of selling were noted. I view the event as operationally neutral and unlikely to affect valuation or trading dynamics.

TL;DR Insider intends minor sale under Rule 144; governance significance minimal.

Rule 144 filings ensure transparency for insider dispositions. The absence of additional sales over the prior quarter and the tiny proportion of stock involved (<0.01%) suggest the move is personal liquidity rather than a governance red flag. There is no indication of undisclosed adverse information. Overall, the filing maintains compliance without raising governance concerns.

Resideo Technologies, Inc. (REZI) ha presentato un Modulo 144 comunicando una prevista cessione di 5.579 azioni ordinarie tramite Morgan Stanley Smith Barney il 07 luglio 2025. Le azioni derivano da unità azionarie vincolate concesse il 16 novembre 2022 e hanno un valore di mercato stimato di 134.342 $. Con 148.503.534 azioni attualmente in circolazione, la vendita rappresenta circa lo 0,004 % del totale delle azioni, una quantità generalmente considerata irrilevante per il flottante della società. Il dichiarante ha segnalato nessuna altra vendita negli ultimi tre mesi e l’avviso non contiene commenti sulle operazioni o sulle prospettive dell’azienda.

Resideo Technologies, Inc. (REZI) presentó un Formulario 144 revelando una disposición planificada de 5.579 acciones comunes a través de Morgan Stanley Smith Barney el 07 de julio de 2025. Las acciones provienen de unidades de acciones restringidas otorgadas el 16 de noviembre de 2022 y tienen un valor de mercado estimado de $134,342. Con 148,503,534 acciones actualmente en circulación, la venta equivale aproximadamente al 0.004 % del total de acciones, una cantidad generalmente considerada insignificante para el flotante de la empresa. El declarante reportó ninguna otra venta en los últimos tres meses y el aviso no contiene comentarios sobre las operaciones o perspectivas de la compañía.

Resideo Technologies, Inc. (REZI)� 2025� 7� 7� Morgan Stanley Smith Barney� 통해 5,579�� 보통� 처분 계획� 공개하는 Form 144� 제출했습니다. 해당 주식은 2022� 11� 16일에 부여된 제한 주식 단위에서 기인하며, 추정 시장 가치는 134,342달러입니�. 현재 148,503,534주가 유통 중인 가운데, 이번 매각은 전체 주식� � 0.004%� 해당하며, 이는 일반적으� 회사 유통 주식 수에 크게 영향� 미치지 않는 수준입니�. 제출자는 지� 3개월 동안 다른 매각� 없었�� 보고했으�, 공지에는 회사 운영이나 전망� 대� 언급� 없습니다.

Resideo Technologies, Inc. (REZI) a déposé un formulaire 144 révélant une cession prévue de 5 579 actions ordinaires via Morgan Stanley Smith Barney le 07 juillet 2025. Les actions proviennent de unités d’actions restreintes attribuées le 16 novembre 2022 et ont une valeur marchande estimée à 134 342 $. Avec 148 503 534 actions actuellement en circulation, la vente représente environ 0,004 % du total des actions, un montant généralement considéré comme négligeable pour le flottant de la société. Le déclarant a indiqué aucune autre vente au cours des trois derniers mois, et l’avis ne contient aucun commentaire sur les opérations ou les perspectives de l’entreprise.

Resideo Technologies, Inc. (REZI) hat ein Formular 144 eingereicht, in dem eine geplante Veräußerung von 5.579 Stammaktien über Morgan Stanley Smith Barney am 07. Juli 2025 offengelegt wird. Die Aktien stammen von Restricted Stock Units, die am 16. November 2022 gewährt wurden, und haben einen geschätzten Marktwert von 134.342 $. Bei derzeit 148.503.534 ausstehenden Aktien entspricht der Verkauf etwa 0,004 % der Gesamtaktien � ein Betrag, der allgemein als unerheblich für den Streubesitz des Unternehmens angesehen wird. Der Meldende gab an, in den letzten drei Monaten keine weiteren Verkäufe getätigt zu haben, und die Mitteilung enthält keine Kommentare zu den Geschäftstätigkeiten oder der Perspektive des Unternehmens.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Muhsin Bilal

(Last) (First) (Middle)
C/O BECTON, DICKINSON AND COMPANY
1 BECTON DRIVE

(Street)
FRANKLIN LAKES NJ 07417

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
BECTON DICKINSON & CO [ BDX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP & President Connected Care
3. Date of Earliest Transaction (Month/Day/Year)
07/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/02/2025 A 12,221(1) A $0 12,221 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.
Donna Kalazdy, by power of attorney from Bilal Muhsin 07/07/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Resideo (REZI) shares are being sold under this Form 144?

5,579 common shares are proposed for sale.

What is the estimated market value of the REZI shares to be sold?

The filing lists an aggregate value of $134,342.32.

What percentage of Resideo’s outstanding shares does the sale represent?

Approximately 0.004 % of the 148,503,534 shares outstanding.

When were the shares originally acquired by the insider?

They were acquired on 16 November 2022 as restricted stock units.

On what date may the proposed sale take place?

The approximate sale date provided is 07 July 2025.

Which broker is handling the transaction for the insider?

The broker of record is Morgan Stanley Smith Barney LLC, Executive Financial Services.
Becton Dickinson & Co

NYSE:BDX

BDX Rankings

BDX Latest News

BDX Latest SEC Filings

BDX Stock Data

49.37B
284.96M
0.56%
93.73%
1.02%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
United States
FRANKLIN LAKES